🔗 Share this article

This year's prestigious award in medical science was awarded for transformative findings that clarify how the body's defense network targets harmful pathogens while protecting the body's own cells.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—share this honor.

The research uncovered unique "sentinels" within the defense system that eliminate rogue defense cells that could harming the organism.

These discoveries are now paving the way for new treatments for immune disorders and cancer.

The winners will divide a monetary award worth 11 million Swedish kronor.

Decisive Findings

"The research has been decisive for comprehending how the immune system functions and the reason we don't all suffer from severe self-attack conditions," commented the chair of the Nobel Committee.

The team's research address a core mystery: In what way does the immune system defend us from numerous infections while keeping our own tissues intact?

Our immune system employs immune cells that scan for signs of disease, even viruses and bacteria it has never encountered.

These cells utilize detectors—called recognition units—that are produced randomly in countless combinations.

This provides the immune system the ability to combat a wide array of invaders, but the unpredictability of the process inevitably produces immune cells that can target the host.

Security Guards of the Body

Researchers earlier knew that a portion of these harmful white blood cells were eliminated in the immune organ—where immune cells mature.

This year's Nobel Prize honors the identification of T-reg cells—described as the immune system's "security guards"—which patrol the system to disarm other defenders that attack the body's own tissues.

We know that this process fails in autoimmune diseases such as type-1 diabetes, MS, and RA.

A prize committee added, "The findings have established a new field of research and accelerated the creation of new treatments, for instance for cancer and autoimmune diseases."

In cancer, regulatory T-cells prevent the body from fighting the growth, so research are aimed at reducing their numbers.

In self-attack disorders, trials are testing boosting T-reg cells so the body is not being harmed. A comparable method could also be effective in reducing the chances of organ transplant rejection.

Pioneering Experiments

Professor Shimon Sakaguchi, from Osaka University, conducted tests on mice that had their thymus extracted, leading to autoimmune disease.

He showed that injecting defense cells from healthy animals could stop the illness—implying there was a system for blocking defenders from harming the body.

Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an genetic autoimmune disease in rodents and humans that led to the identification of a gene critical for how regulatory T-cells function.

"The groundbreaking research has revealed how the immune system is controlled by T-reg cells, preventing it from accidentally attacking the healthy cells," commented a prominent biological science expert.

"The work is a remarkable example of how basic biological study can have broad consequences for public health."